Recent progress in molecular etiology of arrhythmia and anti-arrhythmia drug therapy
Nakamura, H.
Masui. Japanese Journal of Anesthesiology 53 Suppl: S81-S90
2004
ISSN/ISBN: 0021-4892 PMID: 15672738 Document Number: 569145
Document emailed within 1 workday
Related Documents
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15Sokolov, S.F.; Golitsyn, S.P.; Malakhov, V.I.; Bankuzov, V.A.; Koltunova, M.I.; Golitsyn, L.S. 1990: The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor Farmakologiia i Toksikologiia 53(3): 57-60
Tuna, J.L. 1992: Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 385-386
Storozhuk, B.G. 1985: Anti-arrhythmia activity and side effects of various anti-arrhythmia agents Vrachebnoe Delo 3: 41-44
Leclercq, J.F.; Attuel, P.; Milosevic, D.; Coumel, P. 1979: Quantitative evaluation of the efficacy of anti-arrhythmia agents in chronic ventricular arrhythmia Acta Cardiologica 34(1): 35-50
Bracchetti, D.; Mantovani, B.; Naccarella, F.; Lombardi, G.; Palmieri, M. 1980: Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia Bollettino Della Societa Italiana di Cardiologia Suppl: 117-123
Savina, M.D.; Kudrin, A.N. 1982: Anti-arrhythmia activity of fusaric acid N,N-diethylaminoethylamide in experimental arrhythmia models in comparison with novocainamide Farmakologiia i Toksikologiia 45(2): 63-65
Mazur, N.A.; Kurbanov, R.D. 1984: Deterioration in ventricular arrhythmia caused by anti-arrhythmia preparations Terapevticheskii Arkhiv 56(9): 67-70
Lishmanov, I.B.; Maslov, L.N.; Krylatov, A.V.; Ugdyzhekova, D.S.; Gilligan, P.; Tam, S.W. 2000: The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands Eksperimental'naia i Klinicheskaia Farmakologiia 63(2): 39-43
Hohnloser, S.H.; Meinertz, T.; Mehender, M.; Geibel, A.; Just, H. 1988: Induction and increase of cardiac arrhythmia by anti-arrhythmia agents Der Internist 29(5): 338-344
Bonhorst, D. 1992: Choice of anti-arrhythmia agents: the arrhythmia-patient binomial Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 387-389
Honerjäger, P. 1990: New aspects of the molecular effect of anti-arrhythmia agents Herz 15(2): 70-78
Schollmeyer, P. 1973: Arrhythmia following drug therapy Die Medizinische Welt 24(26): 1092-1096
Alboni, P. 1979: Is an electrophysiological study useful for the choice of anti-arrhythmia drug in patients with supraventricular paroxysmal tachycardia? Giornale Italiano di Cardiologia 9(5): 458-461
Follath, F.; Candinas, R.; Frielingsdorf, J. 1993: Therapy of atrial fibrillation with class III anti-arrhythmia agents Herz 18(1): 20-26
Geibel, A.; Zehender, M.; Hohnloser, S.; Landsrath, C.; Meinertz, T.; Just, H. 1988: Diprafenone--comparative study of anti-arrhythmia therapy with propafenone Zeitschrift für Kardiologie 77(7): 464-469
Critelli, G. 1993: Transcatheter ablation: a turning point in anti-arrhythmia therapy Cardiologia 38(10): 661-667
Knipping, W. 1980: Problems of evaluating rare adverse drug reactions using as an example agranulocytosis induced by anti-arrhythmia agents Medizinische Klinik 75(3): 108-115
Toivonen, L.; Heikkilä, J. 1986: Drug therapy of arrhythmia--ECG, a "cosmetic" or benefit to the patient? Duodecim; Laaketieteellinen Aikakauskirja 102(22): 1651-1661
Honerjäger, P.; Schmidt, G. 1993: Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 48(9): 425-429